|
|
|
Volumn 14, Issue 4, 2008, Pages 49-53
|
|
[Combination of reconstructive vascular operations with gene-engineering technologies of angiogenesis stimulation: a present-day policy aimed at improving the remote results of treating patients with lower limb chronic ischaemia].
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENIC FACTOR;
ANGIOGENIN;
PANCREATIC RIBONUCLEASE;
VASCULOTROPIN A;
AGED;
ANGIOGENESIS;
ARTICLE;
BLOOD VESSEL PROSTHESIS;
CHRONIC DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
EXERCISE TEST;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
ISCHEMIA;
LEG;
MALE;
METHODOLOGY;
MIDDLE AGED;
PATHOLOGY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PRACTICE GUIDELINE;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TISSUE ENGINEERING;
TREATMENT OUTCOME;
VASCULAR SURGERY;
VASCULARIZATION;
AGED;
ANGIOGENESIS INDUCING AGENTS;
BLOOD VESSEL PROSTHESIS;
CHRONIC DISEASE;
DRUG THERAPY, COMBINATION;
EXERCISE TEST;
FEMALE;
FOLLOW-UP STUDIES;
GUIDELINE ADHERENCE;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
ISCHEMIA;
LEG;
MALE;
MIDDLE AGED;
NEOVASCULARIZATION, PHYSIOLOGIC;
QUALITY OF LIFE;
RIBONUCLEASE, PANCREATIC;
TIME FACTORS;
TISSUE ENGINEERING;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR SURGICAL PROCEDURES;
|
|
EID: 79958713368
PISSN: 10276661
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
